Demographic and health status variables for patients included in the PASS/MCII cutpoint analyses. Mean (SD) for continuous variables, percentages for counts.
| RA (n = 2898 for PASS & MCII) | PsA (n = 850 for PASS & MCII) | AS (n = 477 for PASS & MCII) | ||||
|---|---|---|---|---|---|---|
| Demographic variables | ||||||
| Age, yrs | 54.6 (13.4) | 48.3 (12.2) | 43.0 (10.2) | |||
| Female | 72.7 | 47.3 | 31.2 | |||
| Disease duration, yrs | 8.0 (9.6) | 7.1 (8.6) | 12.2 (10.0) | |||
| Health Status | ||||||
| Measures | Baseline | 3 months | Baseline | 3 months | Baseline | 3 months |
| PASS | 37.7 | 57.7 | 30.9 | 54.2 | 28.6 | 62.3 |
| MCII | 57.3 | 50.0 | 68.8 | |||
| EQ-5D | 0.46 (0.31) | 0.59 (0.28) | 0.49 (0.29) | 0.61 (0.28) | 0.39 (0.33) | 0.60 (0.34) |
| SF-6D | 0.59 (0.12) | 0.65 (0.13) | 0.60 (0.12) | 0.66 (0.13) | 0.58 (0.11) | 0.68 (0.14) |
| Patient global VAS | 51.8 (24.0) | 37.8 (24.4) | 51.5 (21.6) | 37.8 (23.1) | 57.7 (22.9) | 33.0 (25.1) |
| Pain VAS | 48.7 (24.2) | 35.5 (24.1) | 48.4 (22.2) | 35.0 (22.6) | 53.6 (22.9) | 29.8 (24.2) |
| MHAQ | 0.72 (0.51) | 0.52 (0.47) | 0.63 (0.44) | 0.47 (0.42) | 0.67 (0.45) | 0.40 (0.42) |
PASS: Patient Acceptable Symptom State; MCII: Minimal Clinically Important Improvement; RA: rheumatoid arthritis; PsA: psoriatic arthritis; AS: ankylosing spondylitis; MHAQ: Modified Health Assessment Questionnaire; VAS: visual analog scale; EQ-5D: EuroQol-5 Dimensions; SF-6D: Short-Form-6 Dimensions.